Category Archives:
Abbott raises annual profit forecast after upbeat quarterly results
(Reuters) -Abbott Laboratories raised its full-year adjusted earnings forecast after reporting a rise in quarterly profit, driven by strength in its mainstay businesses and a rebound in COVID-19 test ...
Oct 20, 2021
UK seeks to rein in COVID stimulus despite slowing recovery
By David Milliken LONDON (Reuters) - Britain looks set to become the first big economy to undergo a two-pronged withdrawal of COVID-19 stimulus as finance minister Rishi Sunak sets out tighter budget ...
Oct 20, 2021
Futures flat on worries over supply chain disruptions; Netflix falls
By Devik Jain (Reuters) - U.S. stock index futures were flat on Wednesday as investors weighed the impact of supply chain constraints and inflation on corporate earnings, while Netflix shares remained...
Oct 20, 2021
Verizon adds more postpaid subscribers than expected on 5G strength
(Reuters) -Verizon Communications Inc said on Wednesday it added more postpaid phone subscribers than expected in the third quarter, supported by a steady demand for 5G services. The carrier has been ...
Oct 20, 2021
Netflix workers stage walk-out over Chappelle transgender comments
By Dawn Chmielewski (Reuters) - Netflix Inc employees are staging a walk-out on Wednesday in an unprecedented show of defiance to protest the streaming giant's decision to release comedian Dave Chappe...
Oct 20, 2021
U.S. highway expansions increase traffic and pollution, environmental groups say
By Tina Bellon AUSTIN, Texas (Reuters) - U.S. policies of expanding highways to ease congestion are misguided and lead to an increase in traffic and pollution, environmental advocacy groups said, urgi...
Oct 20, 2021
Senators urge FCC to address surveillance threats to U.S. telecom networks
By David Shepardson WASHINGTON (Reuters) - A group of five U.S. senators urged the Federal Communications Commission (FCC) on Wednesday to address surveillance threats posed by foreign firms providing...
Oct 20, 2021
Cigna’s pharmacy benefit unit to prefer cheaper insulin drug from Viatris
(Reuters) - Cigna Corp's pharmacy benefit unit said on Wednesday it will prefer Viatris Inc and Biocon Biologics Ltd's insulin drug Semglee, a cheaper alternative to Sanofi SA's Lantus, on the list of...
Oct 20, 2021
Biogen posts much smaller-than-expected sales of new Alzheimer’s drug
(Reuters) - Biogen Inc fell well short of Wall Street estimates for third-quarter sales of its Alzheimer's drug Aduhelm on Wednesday, as the drugmaker struggles to sell the treatment to hospitals and ...
Oct 20, 2021
Baker Hughes posts Q3 profit as drilling demand returns
(Reuters) -Baker Hughes Co reported a quarterly profit on Wednesday compared to a year-ago loss, as crude prices recovered to pre-pandemic levels, fueling drilling activity and demand for oilfield ser...
Oct 20, 2021
Peoria, IL, USA
44 °F Overcast
